The potential breakthrough of cancer research may have guidance from the emerging field of nanotheranostics that aims to utilize nanotechnology for diagnostic and therapeutic applications.
Nanoribbon biosensors can be used for detecting biomarkers within the blood and plasma, suitable for precision medicine, and the aim for early and more effective diagnostics